Take Your Practice to the Next Level—Expert Guidance on Individualizing PAH Treatment and Bridging Guidelines to Real-World Care in MAC-LD
| Estimated time to read:
The following content is part of a paid sponsorship and is not an endorsement by CHEST nor does it reflect the views or opinions of CHEST.
Join Answers in CME for two interactive live events designed to sharpen your clinical decision-making.
On Sunday, join our expert faculty as they compete in an electrifying game show-style event. When should you act, what should you change, and which approach best fits the patient in front of you? In this clinical face-off, four real-world PAH cases will put those questions center stage. Follow the faculty as they work through patients whose risk profiles, treatment responses, tolerability concerns, and clinical circumstances call for more than a one-size-fits-all answer. Each case is an opportunity to consider the rationale for timely, risk-based intensification, recognize signals that a patient may need a new strategy, and weigh how novel add-on therapies can fit into a personalized plan. This is your chance to compare your clinical approach with expert thinking, test your judgment along the way, and see which case earns the win. Expect fast decisions and practical takeaways for navigating intermediate- and high-risk PAH.
Monday morning, learn from experts in the field of MAC lung disease how to transform guideline recommendations into real-world care for your patients. MAC lung disease care is evolving, and the decisions extend well beyond selecting a regimen. You can expect a focused discussion on how to turn current evidence into treatment plans that account for disease stage, patient needs, and the realities of longitudinal care. The conversation will examine the clinical profiles of emerging first-line options alongside established regimens. Faculty will explore how to reassess and individualize care when disease remains difficult to manage, helping you think through refractory disease without losing sight of patient-centered goals.
Come prepared with the PAH and MAC lung disease questions that arise in your own practice, and leave with a clearer framework for matching treatment decisions to the person, not just the diagnosis.
SUNDAY – This educational activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.
MONDAY – This educational activity is supported by an educational grant from Insmed.
These symposia are not supported, endorsed, or accredited by CHEST, unless otherwise noted.
